DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,859,180 | -5.2% | 47,800 | -8.3% | 0.12% | -20.1% |
| Q2 2023 | $12,504,000 | +3812095.1% | 52,100 | +3907.7% | 0.15% | +2880.0% |
| Q1 2023 | $328 | -90.7% | 1,300 | -90.2% | 0.01% | -92.8% |
| Q4 2022 | $3,509 | -99.9% | 13,222 | +28.9% | 0.07% | +21.1% |
| Q3 2022 | $2,648,000 | +207.9% | 10,258 | +201.7% | 0.06% | +147.8% |
| Q2 2022 | $860,000 | -84.9% | 3,400 | -80.4% | 0.02% | -76.0% |
| Q4 2021 | $5,700,000 | +1303.9% | 17,323 | +1200.5% | 0.10% | +1271.4% |
| Q3 2021 | $406,000 | -89.5% | 1,332 | -92.2% | 0.01% | -90.9% |
| Q1 2021 | $3,849,000 | -12.0% | 17,099 | -13.2% | 0.08% | -37.9% |
| Q4 2020 | $4,376,000 | +249.2% | 19,698 | +238.5% | 0.12% | +129.6% |
| Q3 2020 | $1,253,000 | +341.2% | 5,820 | +214.3% | 0.05% | +315.4% |
| Q4 2019 | $284,000 | -13.9% | 1,852 | -25.9% | 0.01% | -7.1% |
| Q1 2019 | $330,000 | -3.2% | 2,500 | -20.3% | 0.01% | +55.6% |
| Q3 2018 | $341,000 | -58.6% | 3,137 | -62.4% | 0.01% | -69.0% |
| Q2 2018 | $823,000 | +241.5% | 8,339 | +239.1% | 0.03% | +262.5% |
| Q1 2018 | $241,000 | -89.3% | 2,459 | -90.6% | 0.01% | -86.0% |
| Q3 2017 | $2,245,000 | -14.0% | 26,169 | -15.4% | 0.06% | -27.8% |
| Q2 2017 | $2,609,000 | -93.1% | 30,918 | -93.6% | 0.08% | -91.9% |
| Q4 2016 | $37,708,000 | +638.5% | 484,432 | +643.7% | 0.97% | +709.2% |
| Q3 2016 | $5,106,000 | +365.5% | 65,140 | +499.9% | 0.12% | +421.7% |
| Q2 2016 | $1,097,000 | -27.3% | 10,859 | -31.7% | 0.02% | -41.0% |
| Q1 2016 | $1,509,000 | -70.7% | 15,909 | -71.3% | 0.04% | -73.1% |
| Q4 2015 | $5,157,000 | +155.8% | 55,522 | +134.7% | 0.14% | +113.2% |
| Q3 2015 | $2,016,000 | -92.3% | 23,659 | -92.3% | 0.07% | -91.1% |
| Q2 2015 | $26,259,000 | +145.3% | 306,800 | +143.4% | 0.77% | +124.3% |
| Q1 2015 | $10,703,000 | -50.7% | 126,068 | -55.9% | 0.34% | -56.4% |
| Q3 2014 | $21,721,000 | +10.4% | 285,876 | +14.4% | 0.78% | +4.0% |
| Q2 2014 | $19,683,000 | +982.7% | 250,000 | +931.2% | 0.75% | +879.2% |
| Q1 2014 | $1,818,000 | +254.4% | 24,243 | +265.1% | 0.08% | +208.0% |
| Q4 2013 | $513,000 | +80.6% | 6,640 | +62.0% | 0.02% | +108.3% |
| Q3 2013 | $284,000 | – | 4,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |